jRCTs051210106已完成不适用
The Effect of Suplatast Tosilate for interstitial Cystitis: A randomized controlled open-label trial (ESTOC study)
未提供0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients diagnosed as IC
排除标准
- •Patients who are allergic to the treatment drug
- •Patients with serious liver disease (AST (GOT) or ALT (GPT) 100 IU / L or higher)
- •Patients who are pregnant or may become pregnant
- •Patients who took the study drug within 3 months before the start of study drug administration
- •Patients who are judged to be inappropriate as subjects by the investigator
结局指标
主要结局
-
Change of interstitial cystitis symptom scores
次要结局
- Frequency volume charts for two days
- Urinanalysis
- Safty
- Participants divided by serum anandamide concentration
- Participants divided by serum 1-linolenoylglycrophosphocholine concentration